(VNDA) Vanda Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Vanda Pharmaceuticals | (VNDA) share price targets
Complete technical analysis of Vanda Pharmaceuticals (VNDA) by charts plus indicators, forecast predictions and share price targets for Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-09 View latest technical analysis
10 day averaged volume of Vanda Pharmaceuticals is 479158
Date | Daily Closing Price | Open | High | Low | Volume |
09 Mon Sep 2024 | 5.02 | 5.02 | 5.15 | 4.99 | 1.135 times |
06 Fri Sep 2024 | 5.02 | 5.08 | 5.12 | 4.92 | 0.979 times |
05 Thu Sep 2024 | 5.08 | 5.07 | 5.13 | 4.99 | 0.909 times |
04 Wed Sep 2024 | 5.08 | 5.00 | 5.10 | 4.96 | 1.111 times |
03 Tue Sep 2024 | 5.08 | 5.28 | 5.35 | 5.06 | 1.19 times |
30 Fri Aug 2024 | 5.29 | 5.29 | 5.31 | 5.17 | 1.253 times |
30 Fri Aug 2024 | 5.29 | 5.29 | 5.31 | 5.17 | 1.254 times |
29 Thu Aug 2024 | 5.22 | 5.28 | 5.33 | 5.22 | 0.702 times |
28 Wed Aug 2024 | 5.27 | 5.35 | 5.36 | 5.21 | 0.561 times |
27 Tue Aug 2024 | 5.35 | 5.46 | 5.48 | 5.32 | 0.73 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 5.1, but if it comes above 5.1, then a intra day buy could be more profitable.
If you take a sell trade below 5.1, then use 5.1 as stoploss and 4.9 as target. However if you take a buy trade in stock , then use 5.1 as stoploss and 5.23 as target.
Share price targets for Vanda Pharmaceuticals (VNDA)
Target Type | Value |
Downside Target | 4.62 |
Downside Target | 4.92 |
Upside Target | 5.31 |
Upside Target | 5.35 |
Upside Target | 5.48 |
Upside Target | 5.53 |
Upside Target | 5.95 |
Upside Target | 5.97 |
Upside Target | 6.37 |
Upside Target | 6.75 |
Intraday share price targets for Vanda Pharmaceuticals (VNDA)
Target Type | Value |
Downside Intraday Target | 4.96 |
Downside Intraday Target | 4.89 |
Upside Intraday Target | 5.12 |
Upside Intraday Target | 5.21 |
Upside Intraday Target | 5.05 |
Weekly technical analysis of Vanda Pharmaceuticals (VNDA)
Date | Weekly Closing Price | Open | High | Low | Volume |
09 Mon Sep 2024 | 5.02 | 5.02 | 5.15 | 4.99 | 0.271 times |
06 Fri Sep 2024 | 5.02 | 5.28 | 5.35 | 4.92 | 3.343 times |
30 Fri Aug 2024 | 5.29 | 5.29 | 5.31 | 5.17 | 0.275 times |
30 Fri Aug 2024 | 5.29 | 5.50 | 5.53 | 5.17 | 1.07 times |
23 Fri Aug 2024 | 5.46 | 5.20 | 5.48 | 5.20 | 0.716 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Vanda Pharmaceuticals (VNDA)
Date | Monthly Closing Price | Open | High | Low | Volume |
09 Mon Sep 2024 | 5.02 | 5.28 | 5.35 | 4.92 | 0.203 times |
30 Fri Aug 2024 | 5.29 | 5.86 | 5.97 | 5.05 | 0.767 times |
31 Wed Jul 2024 | 5.84 | 5.68 | 6.37 | 5.13 | 0.496 times |
28 Fri Jun 2024 | 5.65 | 5.17 | 6.75 | 4.92 | 1.32 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Vanda Pharmaceuticals (VNDA)
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Vanda Pharmaceuticals in short term and the sell signal is strong.
Vanda Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Vanda Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Vanda Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.16 and Vanda Pharmaceuticals (VNDA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vanda Pharmaceuticals (VNDA) stock. Volume based technical analysis of Vanda Pharmaceuticals (VNDA) stock is negative.
Vanda Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Vanda Pharmaceuticals in short term and the sell signal is strong.
Vanda Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Vanda Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Vanda Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.16 and Vanda Pharmaceuticals (VNDA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vanda Pharmaceuticals (VNDA) stock. Volume based technical analysis of Vanda Pharmaceuticals (VNDA) stock is negative.
Vanda Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.